MEDIWOUND
MediWound is a biotechnology niche specialty company. Established in 2001, MediWound is focused on developing, manufacturing, and globally commercializing innovative products that address unmet needs in the fields of severe burn and chronic wound management. MediWound’s goal is to provide healthcare professionals and patients with its innovative, burn wound eschar removal agent, NexoBrid™. NexoBrid™ successfully completed clinical development in hospitalized burn wounds and is approved and ready to launch in Europe.
MEDIWOUND
Industry:
Biotechnology Manufacturing Medical Device
Founded:
2001-01-01
Address:
Yavne, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.mediwound.com
Total Employee:
11+
Status:
Active
Contact:
(972) 779-7141
Total Funding:
47.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Wordpress Plugins Global Site Tag
Similar Organizations
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Norman Biological Technology
Norman Biological Technology is a manufacturer of automated chemiluminescence system.
Pilot Biotechnology
Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.
Current Advisors List
Board_member
Current Employees Featured
Boaz Gur-Lavie Chief Financial Officer @ MediWound
Chief Financial Officer
2019-06-01
Gal Cohen CEO @ MediWound
CEO
Lior Rosenberg Co-Founder & Chief Medical Officer @ MediWound
Co-Founder & Chief Medical Officer
Founder
Stock Details
Investors List
U.S. Department of Defense
U.S. Department of Defense investment in Grant - MediWound
Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - MediWound
Clal Biotechnology Industries
Clal Biotechnology Industries investment in Venture Round - MediWound
Official Site Inspections
http://www.mediwound.com Semrush global rank: 6.44 M Semrush visits lastest month: 1.01 K
- Host name: ns3.hostisrael.co.il
- IP address: 62.219.67.159
- Location: Israel
- Latitude: 31.5
- Longitude: 34.75
- Timezone: Asia/Jerusalem
More informations about "MediWound"
About - Mediwound
MediWound Ltd. (Nasdaq: MDWD) is the global leader in next-generation enzymatic therapeutics focused on non-surgical tissue repair.Specializing in the development, production and …See details»
MediWound - Crunchbase Company Profile & Funding
MediWound is a biotechnology niche-specialty company. Established in 2001, MediWound is focused on developing, manufacturing, and globally commercializing innovative products that …See details»
MediWound Ltd. - 1593984 - 2024 - SEC.gov
ISRAEL (Jurisdiction of incorporation or organization) ... The “MediWound” design logo, “MediWound,” “NexoBrid,” “EscharEx” and other trademarks or service marks of MediWound Ltd. appearing in this annual report are the property of …See details»
MediWound - LinkedIn
MediWound | 3,634 followers on LinkedIn. The global leader in next-generation enzymatic therapeutics focused on non-surgical tissue repair | MediWound Ltd. (Nasdaq: MDWD) is the …See details»
Medi Wound - Org Chart, Teams, Culture & Jobs - The Org
MediWound Ltd. is a biopharmaceutical company. The Company focuses on developing, manufacturing and commercializing therapeutics products in the fields of severe burns, chronic …See details»
MediWound - Israeli Startup | Startup Nation Finder
Jan 27, 2025 MediWound offers next-generation enzymatic therapeutics focused on non-surgical tissue repair. Specializing in the development, production and commercialization of solutions that seek to replace existing standards of care, …See details»
MediWound - Funding, Financials, Valuation & Investors
MediWound is a biotechnology specialty company focused on developing, manufacturing and commercializing innovative wound care products. New. Resources. ... How much funding has …See details»
MediWound Company Profile - Office Locations, Competitors
Oct 29, 2024 MediWound has 5 employees across 3 locations and $18.69 m in annual revenue in FY 2023. See insights on MediWound including office locations, competitors, revenue, …See details»
MediWound - Contacts, Employees, Board Members, Advisors
MediWound is a biotechnology specialty company focused on developing, manufacturing and commercializing innovative wound care products. ... Experience the new Crunchbase, …See details»
MediWound - Overview, News & Similar companies | ZoomInfo.com
MediWound is a fully integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutics based on its patented proteolytic …See details»
Press release - Mölnlycke Health Care announces US $15m …
Jul 15, 2024 MediWound first drug, NexoBrid®, is an FDA and EMA-approved orphan biologic for eschar removal in deep partial-thickness and/or full-thickness thermal burns, which can …See details»
Organization: MediWound - Cbonds.com
MediWound. Information about the issuer. News and credit ratings. . Tables with accounting and financial reporting.See details»
MediWound 2025 Company Profile: Stock Performance & Earnings …
MediWound General Information Description. MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic …See details»
MediWound (MDWD) Company Profile & Description - Stock …
Mar 20, 2014 MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and …See details»
MediWound Announces Executive Leadership Changes
YAVNE, Israel, March 12, 2019 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet …See details»
MediWound Expands its Global Leadership Team to Help Drive …
Mar 6, 2023 These and other significant factors are discussed in greater detail in MediWound’s annual report on Form 20-F for the year ended December 31, 2021, filed with the Securities …See details»
Governance MediWound Ltd. - MarketScreener.com
Jun 29, 2022 Mediwound Ltd is an Israel-based biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue …See details»
Governance MediWound Ltd. Börse Stuttgart - MarketScreener.com
Jun 29, 2022 Mediwound Ltd is an Israel-based biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue …See details»
MediWound Reports Fourth Quarter and Full Year 2024
3 days ago Contacts:. Hani Luxenburg Chief Financial Officer MediWound Ltd. ir@mediwound.com Daniel Ferry Managing Director, LifeSci Advisors 617-430-7576 …See details»
MediWound Reports Fourth Quarter and Full Year 2024 Financial …
These and other significant factors are discussed in greater detail in MediWound’s annual report on Form 20-F for the year ended December 31, 2024, filed with the Securities and Exchange …See details»